Skip to main content Accessibility help
×
Home

Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer’s Disease

  • Lisa Quenon (a1), Laurence Dricot (a1), John L. Woodard (a1) (a2), Bernard Hanseeuw (a1) (a3) (a4), Nathalie Gilis (a5), Renaud Lhommel (a6) and Adrian Ivanoiu (a1) (a3)...

Abstract

Objectives: Relatively few studies have investigated relationships between performance on clinical memory measures and indexes of underlying neuropathology related to Alzheimer’s disease (AD). This study investigated predictive relationships between Free and Cued Selective Reminding Test (FCSRT) cue efficiency (CE) and free-recall (FR) measures and brain amyloid levels, hippocampal volume (HV), and regional cortical thickness. Methods: Thirty-one older controls without memory complaints and 60 patients presenting memory complaints underwent the FCSRT, amyloid imaging using [F18]-flutemetamol positron emission tomography, and surface-based morphometry (SBM) using brain magnetic resonance imaging. Three groups were considered: patients with high (Aβ+P) and low (Aβ− P) amyloid load and controls with low amyloid load (Aβ− C). Results: Aβ+P showed lower CE than both Aβ− groups, but the Aβ− groups did not differ significantly. In contrast, FR discriminated all groups. SBM analyses revealed that CE indexes were correlated with the cortical thickness of a wider set of left-lateralized temporal and parietal regions than FR. Regression analyses demonstrated that amyloid load and left HV independently predicted FCSRT scores. Moreover, CE indexes were predicted by the cortical thickness of some regions involved in early AD, such as the entorhinal cortex. Conclusions: Compared to FR measures, CE indexes appear to be more specific for differentiating persons on the basis of amyloid load. Both CE and FR performance were predicted independently by brain amyloid load and reduced left HV. However, CE performance was also predicted by the cortical thickness of regions known to be atrophic early in AD. (JINS, 2016, 22, 991–1004)

Copyright

Corresponding author

Correspondence and reprint requests to: Lisa Quenon, Avenue Hippocrate 10, Centre de Revalidation Neuropsychologique, 1200 Woluwe-Saint-Lambert, Belgium. E-mail: lisa.quenon@uclouvain.be

References

Hide All
Ahn, H. J., Seo, S. W., Chin, J., Suh, M. K., Lee, B. H., Kim, S. T., & Na, D. L. (2011). The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer’s disease: A surface-based morphometric analysis. Neuropsychologia, 49(14), 39313945. doi:10.1016/j.neuropsychologia.2011.10.010
Albert, M. S. (1996). Cognitive and neurobiologic markers of early Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 93(24), 1354713551.
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., & Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270279. doi:10.1016/j.jalz.2011.03.008
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th Ed.). Washington, DC: American Psychiatric Association.
Atienza, M., Atalaia-Silva, K. C., Gonzalez-Escamilla, G., Gil-Neciga, E., Suarez-Gonzalez, A., & Cantero, J. L. (2011). Associative memory deficits in mild cognitive impairment: The role of hippocampal formation. Neuroimage, 57(4), 13311342. doi:10.1016/j.neuroimage.2011.05.047
Becker, J. A., Hedden, T., Carmasin, J., Maye, J., Rentz, D. M., Putcha, D., & Johnson, K. A. (2011). Amyloid-beta associated cortical thinning in clinically normal elderly. Annals of Neurology, 69(6), 10321042. doi:10.1002/ana.22333
Blennow, K., Mattsson, N., Scholl, M., Hansson, O., & Zetterberg, H. (2015). Amyloid biomarkers in Alzheimer’s disease. Trends in Pharmacological Sciences, 36(5), 297309. doi:10.1016/j.tips.2015.03.002
Bonner-Jackson, A., Mahmoud, S., Miller, J., & Banks, S. J. (2015). Verbal and non-verbal memory and hippocampal volumes in a memory clinic population. Alzheimer’s Research & Therapy, 7(1), 61. doi:10.1186/s13195-015-0147-9
Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropatholigica, 82(4), 239259.
Carlesimo, G. A., Perri, R., & Caltagirone, C. (2011). Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer’s disease: A review of the evidence. Neuropsychology Review, 21(1), 5465. doi:10.1007/s11065-010-9153-7
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2000). Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology, 55(12), 18471853.
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., & Nelson, P. T. (2014). Primary age-related tauopathy (PART): A common pathology associated with human aging. Acta Neuropatholigica, 128(6), 755766. doi:10.1007/s00401-014-1349-0
Desikan, R. S., Segonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., & Killiany, R. J. (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage, 31(3), 968980. doi:10.1016/j.neuroimage.2006.01.021
Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., & Buckner, R. L. (2009). The cortical signature of Alzheimer’s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cerebral Cortex, 19(3), 497510. doi:10.1093/cercor/bhn113
Dickerson, B. C., Feczko, E., Augustinack, J. C., Pacheco, J., Morris, J. C., Fischl, B., & Buckner, R. L. (2009). Differential effects of aging and Alzheimer’s disease on medial temporal lobe cortical thickness and surface area. Neurobiology of Aging, 30(3), 432440. doi:10.1016/j.neurobiolaging.2007.07.022
Dickerson, B. C., Fenstermacher, E., Salat, D. H., Wolk, D. A., Maguire, R. P., Desikan, R., & Fischl, B. (2008). Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. Neuroimage, 39(1), 1018. doi:10.1016/j.neuroimage.2007.08.042
Dierckx, E., Engelborghs, S., De Raedt, R., Van Buggenhout, M., De Deyn, P. P., Verte, D., & Ponjaert-Kristoffersen, I. (2009). Verbal cued recall as a predictor of conversion to Alzheimer’s disease in mild cognitive impairment. International Journal of Geriatric Psychiatry, 24(10), 10941100. doi:10.1002/gps.2228
Dore, V., Villemagne, V. L., Bourgeat, P., Fripp, J., Acosta, O., Chetelat, G., & Rowe, C. C. (2013). Cross-sectional and longitudinal analysis of the relationship between Abeta deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. JAMA Neurology, 70(7), 903911. doi:10.1001/jamaneurol.2013.1062
Dubois, B., Feldman, H. H., Jacova, C., Dekosky, S. T., Barberger-Gateau, P., Cummings, J., & Scheltens, P. (2007). Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurology, 6(8), 734746. doi:10.1016/S1474-4422(07)70178-3
Ferguson, C. J. (2009). An effect size primer: A guide for clinicians and researchers. Professional Psychology: Research and Practice, 40(5), 532538. doi:10.1037/a0015808
Fischl, B., Salat, D. H., van der Kouwe, A. J., Makris, N., Segonne, F., Quinn, B. T., & Dale, A. M. (2004). Sequence-independent segmentation of magnetic resonance images. Neuroimage, 23(Suppl 1), S69S84. doi:10.1016/j.neuroimage.2004.07.016
Frisoni, G. B., Prestia, A., Zanetti, O., Galluzzi, S., Romano, M., Cotelli, M., &Geroldi, C. (2009). Markers of Alzheimer’s disease in a population attending a memory clinic. Alzheimer’s & Dementia, 5(4), 307317. doi:10.1016/j.jalz.2009.04.1235
Grober, E., & Buschke, H. (1987). Genuine memory deficits in dementia. Developmental Neuropsychology, 3, 1336.
Grober, E., Lipton, R. B., Hall, C., & Crystal, H. (2000). Memory impairment on free and cued selective reminding predicts dementia. Neurology, 54(4), 827832.
Grober, E., Sanders, A. E., Hall, C., & Lipton, R. B. (2010). Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Disease & Associated Disorders, 24(3), 284290. doi:10.1097/WAD.0b013e3181cfc78b
Hanseeuw, B., Dricot, L., Kavec, M., Grandin, C., Seron, X., & Ivanoiu, A. (2011). Associative encoding deficits in amnestic mild cognitive impairment: A volumetric and functional MRI study. Neuroimage, 56(3), 17431748. doi:10.1016/j.neuroimage.2011.03.034
Hurtz, S., Woo, E., Kebets, V., Green, A. E., Zoumalan, C., Wang, B., & Apostolova, L. G. (2014). Age effects on cortical thickness in cognitively normal elderly individuals. Dementia & Geriatric Cognitive Disorders Extra, 4(2), 221227. doi:10.1159/000362872
Ivanoiu, A., Adam, S., Van der Linden, M., Salmon, E., Juillerat, A. C., Mulligan, R., & Seron, X. (2005). Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer’s disease. Journal of Neurology, (1), 4755. doi:10.1007/s00415-005-0597-2
Ivanoiu, A., Dricot, L., Gilis, N., Grandin, C., Lhommel, R., Quenon, L., &Hanseeuw, B. (2015). Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer’s disease with disease-related biomarkers. Journal of Alzheimer’s Disease, 43(3), 835847. doi:10.3233/JAD-140651
Jack, C. R. Jr. (2014). PART and SNAP. Acta Neuropatholigica, 128(6), 773776. doi:10.1007/s00401-014-1362-3
Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., & Trojanowski, J. Q. (2013). Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12(2), 207216. doi:10.1016/S1474-4422(12)70291-0
Jack, C. R. Jr., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., & Petersen, R. C. (2008). 11C PiB and structural MRI provide complementary information in imaging of Alzheimer’s disease and amnestic mild cognitive impairment. Brain, 131(Pt 3), 665680. doi:10.1093/brain/awm336
Jongbloed, W., Bruggink, K. A., Kester, M. I., Visser, P. J., Scheltens, P., Blankenstein, M. A., & Veerhuis, R. (2015). Amyloid-beta oligomers relate to cognitive decline in Alzheimer’s disease. Journal of Alzheimer’s Disease, 45(1), 3543. doi:10.3233/JAD-142136
Lemaitre, H., Goldman, A. L., Sambataro, F., Verchinski, B. A., Meyer-Lindenberg, A., Weinberger, D. R., &Mattay, V. S. (2012). Normal age-related brain morphometric changes: Nonuniformity across cortical thickness, surface area and gray matter volume? Neurobiology of Aging, 33(3), 617.e1–9. doi:10.1016/j.neurobiolaging.2010.07.013
Lerch, J. P., Pruessner, J. C., Zijdenbos, A., Hampel, H., Teipel, S. J., & Evans, A. C. (2005). Focal decline of cortical thickness in Alzheimer’s disease identified by computational neuroanatomy. Cerebral Cortex, 15(7), 9951001. doi:10.1093/cercor/bhh200
Llado-Saz, S., Atienza, M., & Cantero, J. L. (2015). Increased levels of plasma amyloid-beta are related to cortical thinning and cognitive decline in cognitively normal elderly subjects. Neurobiology of Aging, 36(10), 27912797. doi:10.1016/j.neurobiolaging.2015.06.023
Markesbery, W. R. (2010). Neuropathologic alterations in mild cognitive impairment: A review. Journal of Alzheimer’s Disease, 19(1), 221228. doi:10.3233/JAD-2010-1220
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34(7), 939944.
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., … Alzheimer’s Disease Neuroimaging Initiative. (2009). Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain, 132(Pt 5), 13101323. doi:10.1093/brain/awn320
Myers, R. (1990). Classical and modern regression with application (2nd Ed.). Boston, MA: Duxbury Press.
Nho, K., Risacher, S. L., Crane, P. K., DeCarli, C., Glymour, M. M., & Habeck, C., … Alzheimer’s Disease Neuroimaging Initiative. (2012). Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease. Brain Imaging and Behavior, 6(4), 551567. doi:10.1007/s11682-012-9203-2
Ong, K., Villemagne, V. L., Bahar-Fuchs, A., Lamb, F., Chetelat, G., Raniga, P., & Rowe, C. C. (2013). (18)F-florbetaben Abeta imaging in mild cognitive impairment. Alzheimer’s Research & Therapy, 5(1), 4. doi:10.1186/alzrt158
Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183194. doi:10.1111/j.1365-2796.2004.01388.x
Pillon, B., Deweer, B., Michon, A., Malapani, C., Agid, Y., & Dubois, B. (1994). Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neurology, 44(7), 12641270.
R Development Core Team. (2015). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
Rabinovici, G. D., & Jagust, W. J. (2009). Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo. Behavioral Neurology, 21(1), 117128. doi:10.3233/BEN-2009-0232
Rami, L., Fortea, J., Bosch, B., Sole-Padulles, C., Llado, A., Iranzo, A., & Molinuevo, J. L. (2011). Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients. Journal of Alzheimer’s Disease, 23(2), 319326. doi:10.3233/JAD-2010-101422
Rami, L., Sole-Padulles, C., Fortea, J., Bosch, B., Llado, A., Antonell, A., & Molinuevo, J. L. (2012). Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD. International Journal of Geriatric Psychiatry, 27(2), 127134. doi:10.1002/gps.2696
Saka, E., Mihci, E., Topcuoglu, M. A., & Balkan, S. (2006). Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer’s disease and mild cognitive impairment in Turkish people. Archives of Clinical Neuropsychology, 21(7), 745751. doi:10.1016/j.acn.2006.08.007
Sarazin, M., Berr, C., De Rotrou, J., Fabrigoule, C., Pasquier, F., Legrain, S., & Dubois, B. (2007). Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology, 69(19), 18591867. doi:10.1212/01.wnl.0000279336.36610.f7
Sarazin, M., Chauvire, V., Gerardin, E., Colliot, O., Kinkingnehun, S., de Souza, L. C., & Dubois, B. (2010). The amnestic syndrome of hippocampal type in Alzheimer’s disease: An MRI study. Journal of Alzheimer’s Disease, 22(1), 285294. doi:10.3233/JAD-2010-091150
Sperling, R. (2007). Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer’s disease. Annals of the New York Academy of Sciences, 1097, 146155. doi:10.1196/annals.1379.009
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., & Phelps, C. H. (2011). Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 280292. doi:10.1016/j.jalz.2011.03.003
Stevens, J. P. (2002). Applied multivariate statistics for the social sciences (4th Ed.). Mahwah, NJ: Lawrence Erlbaum Associates.
Thambisetty, M., Wan, J., Carass, A., An, Y., Prince, J. L., & Resnick, S. M. (2010). Longitudinal changes in cortical thickness associated with normal aging. Neuroimage, 52(4), 12151223. doi:10.1016/j.neuroimage.2010.04.258
Tounsi, H., Deweer, B., Ergis, A. M., Van der Linden, M., Pillon, B., Michon, A., & Dubois, B. (1999). Sensitivity to semantic cuing: An index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Disease & Associated Disorders, 13(1), 3846.
Trojanowski, J. Q., Vandeerstichele, H., Korecka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., … Alzheimer’s Disease Neuroimaging Initiative. (2010). Update on the biomarker core of the Alzheimer’s Disease Neuroimaging Initiative subjects. Alzheimer’s & Dementia, 6(3), 230238. doi:10.1016/j.jalz.2010.03.008
Troyer, A. K., Murphy, K. J., Anderson, N. D., Craik, F. I., Moscovitch, M., Maione, A., &Gao, F. (2012). Associative recognition in mild cognitive impairment: Relationship to hippocampal volume and apolipoprotein E. Neuropsychologia, 50(14), 37213728. doi:10.1016/j.neuropsychologia.2012.10.018
Troyer, A. K., Murphy, K. J., Anderson, N. D., Hayman-Abello, B. A., Craik, F. I., & Moscovitch, M. (2008). Item and associative memory in amnestic mild cognitive impairment: Performance on standardized memory tests. Neuropsychology, 22(1), 1016. doi:10.1037/0894-4105.22.1.10
Van der Linden, M., Coyette, F., Poitrenaud, J., Kalafat, M., Calicis, F., Wyns, C., … GRENEM. (2004). L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In M. Van der Linden, S. Adam, A. Agniel, C. Baisset Mouly, F. Bardet, F. Coyette, B. Desgranges, B. Deweer, A.-M. Ergis, M.-C. Gély-Nargeot, L. Grimomprez, A. C. Juillerat, M. Kalafat, J. Poitrenaud, F. Sellal, & C. Thomas-Antérion (Eds.), L’évaluation des troubles de la mémoire. Présentation de quatre tests de mémoire épisodique (avec leur étalonnage). Marseille: Solal.
Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., & Brooks, D. J. (2010). 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Annals of Neurology, 68(3), 319329. doi:10.1002/ana.22068
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., … Australian Lifestyle Research Group. (2013). Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study. Lancet Neurology, 12(4), 357367. doi:10.1016/S1474-4422(13)70044-9
Villemagne, V. L., Pike, K. E., Chetelat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., & Rowe, C. C. (2011). Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Annals of Neurology, 69(1), 181192. doi:10.1002/ana.22248
Wagner, M., Wolf, S., Reischies, F. M., Daerr, M., Wolfsgruber, S., Jessen, F., & Wiltfang, J. (2012). Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology, 78(6), 379386. doi:10.1212/WNL.0b013e318245f447
Wisse, L. E., Butala, N., Das, S. R., Davatzikos, C., Dickerson, B. C., Vaishnavi, S. N., … Alzheimer’s Disease Neuroimaging Initiative. (2015). Suspected non-AD pathology in mild cognitive impairment. Neurobiolology of Aging, 36(12), 31523162. doi:10.1016/j.neurobiolaging.2015.08.029
Xie, J., Gabelle, A., Dorey, A., Garnier-Crussard, A., Perret-Liaudet, A., Delphin-Combe, F., & Krolak-Salmon, P. (2014). Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer’s disease signature. Journal of Alzheimer’s Disease, 41(4), 11091116. doi:10.3233/JAD-131916

Keywords

Type Description Title
PDF
Supplementary materials

Quenon supplementary material
Quenon supplementary material 1

 PDF (12.1 MB)
12.1 MB
PDF
Supplementary materials

Quenon supplementary material
Quenon supplementary material 2

 PDF (6.1 MB)
6.1 MB
WORD
Supplementary materials

Quenon supplementary material
Quenon supplementary material 3

 Word (91 KB)
91 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed